American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
NCT04185844
Summary
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.
Eligibility
Inclusion Criteria: * Glomerular Filtration Rate (GFR): eGFR of =\>61\<80 and microalbuminuria \> 30 or eGRF of =\<60 (no microalbuminuria required). Exclusion Criteria: 1. Unable or unwilling to provide informed consent 2. life expectancy \<3 years; 3. institutionalized subjects; 4. End stage renal disease or renal transplant; 5. renal cancer; 6. myeloma; 7. immunosuppression; 8. Polycystic kidney disease; 9. participation in any clinical trial, 10. current pregnancy 11. current incarceration. 12. Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
Conditions6
Locations3 sites
Arizona
1 siteNew Mexico
2 sitesBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04185844